Effect of metabolic acidosis on hyperlipidemia in uremia

Pediatric Nephrology

Volumn 13, Issue 9, 1999, Pages 891-893

  Mak, Robert H K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Acidosis; Cholesterol; Hemodialysis; High density lipoprotein cholesterol; Triglycerides

Indexed keywords

ANTIHYPERTENSIVE AGENT; BICARBONATE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; CALCIUM ION; CHOLESTEROL; CREATININE; DIHYDROTACHYSTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEPHROVITE; NIFEDIPINE; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM; SODIUM; SODIUM CHLORIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA;

ADOLESCENT; ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PH; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; METABOLIC ACIDOSIS; ORAL DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA; VITAMIN BLOOD LEVEL;

ACIDOSIS; ADOLESCENT; ADULT; CARBONATES; CASE-CONTROL STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; RENAL DIALYSIS; SODIUM BICARBONATE; UREMIA;

EID: 0032762367     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050722     Document Type: Article

References (15)

1. Chan MK, Varghese Z, Moorhead JF (1981) Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 19: 625-637
2. Ponticelli C, Barbi G, Cantaluppi A, Donati C, Annoni G, Branacaccio D (1978) Lipid abnormalities in maintenance dialysis patients and renal transplant recipients. Kidney Int 13 [Suppl 8]:S72-S78
3. Grutzmacher P, Marz W, Peschke P, Gross W, Schoeppe W (1988) Lipoproteins and apolipoproteins during the progression of chronic renal disease. Nephron 50:103-111
4. Senti M, Romero R. Pedro-Botet J, Pelegri A, Noguer X, Rubres-Prat J (1992) Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394-1399
5. Cattran DC, Fenton SA, Wilson DR, Steiner G (1976) Defective triglyceride removal in lipemia associated with peritoneal and hemodialysis. Ann Intern Med 85:29-33
6. Hahn R, Oette K, Mondorg H, Finke K, Sieberth HG (1983) Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48:279-288
7. Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD (1995) Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure. Miner Electrolyte Metab 21:398-402
8. Lind L, Lithell H, Wengle B, Wrege U, Ljunghall S (1988) A pilot study of metabolic effects of intravenously given alphacalcidol in patients with chronic renal failure. Scand J Urol Nephrol 22:129-222
9. 3 treatment on lipid levels in uremic hemodialysis patients. Int J Artif Organs 15:704-707
10. Massry SG, Akmal M (1989) Lipid abnormalities, renal failure and parathyroid hormone. Am J Med 87:42-44
11. Akmal M, Kasim SE, Soliman AR, Massry SG (1990) Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37:854-858
12. Liang K, Oveisi F, Vaziri ND (1998) Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Kidney Int 53:626-630
13. Mak RHK (1998) 1.25 Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53:1353-1357
14. Beck N, Kim HP, Kim S (1975) Effect of metabolic acidosis on renal action of parathyroid hormone. Am J Physiol 228: 1483-1488
15. Kawashima K, Kraut JA, Kurokawa K (1982) Metabolic acidosis suppresses 25-hydroxyvitamin D3-1α-hydroxylase in the rat kidney. Distinct site and mechanism of action. J Clin Invest 70:135-140